The new CleanSpark bitcoin mine in Tennessee https://t.co/n1TiDm5SvV ...

Company achieves 50 EH/s mid-year target 12,608 BTC treasury, all self-mined LAS VEGAS, July 7, 2025 /PRNewswire/ -- CleanSpark, Inc. (Nasdaq: CLSK), America's Bitcoin Miner® (the "Company"), today released its unaudited Bitcoin mining and operations update for the month ended June 30, 2025. "June 2025 marked a milestone month for CleanSpark," said Zach Bradford, CEO and President. "We achieved our mid-year target of reaching 50 EH/s of operational hashrate, becoming the first Bitcoin miner to do so entirel ...

Company Performance - CleanSpark (CLSK) experienced a decline of 1.84% in the latest trading session, closing at $12.25, which lagged behind the S&P 500's daily gain of 0.83% [1] - Prior to this session, CleanSpark's shares had increased by 30.95%, significantly outperforming the Finance sector's gain of 3.44% and the S&P 500's gain of 4.99% [1] Earnings Expectations - Analysts anticipate CleanSpark will report earnings of -$0.02 per share in the upcoming earnings report, indicating a year-over-year decline of 300% [2] - The Zacks Consensus Estimate for revenue is projected at $188.79 million, reflecting an increase of 81.34% compared to the same period last year [2] Full-Year Estimates - For the full year, Zacks Consensus Estimates predict earnings of $0.64 per share and revenue of $758.76 million, representing year-over-year changes of +346.15% and +100.22%, respectively [3] Analyst Forecast Revisions - Recent revisions to analyst forecasts for CleanSpark are important as they often indicate near-term business trends, with upward revisions suggesting analysts' positive outlook on the company's operations and profit generation capabilities [4] Zacks Rank System - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), has a strong historical performance, with 1 rated stocks delivering an average annual return of +25% since 1988 [6] - CleanSpark currently holds a Zacks Rank of 3 (Hold), with a consensus EPS projection having decreased by 113.33% in the past 30 days [6] Valuation Metrics - CleanSpark is trading at a Forward P/E ratio of 19.42, which is higher than the industry average Forward P/E of 12.15, indicating that CleanSpark is trading at a premium compared to its peers [7] - The Financial - Miscellaneous Services industry, to which CleanSpark belongs, has a Zacks Industry Rank of 151, placing it within the bottom 39% of over 250 industries [7]

Core Viewpoint - CleanSpark's stock performance has outpaced major indices, with a notable increase over the past month, while upcoming financial results are anticipated to show significant revenue growth despite a projected decline in earnings per share [1][2][3]. Group 1: Stock Performance - CleanSpark (CLSK) increased by 1.98% to $10.81, outperforming the S&P 500, which gained 0.8% [1] - Over the past month, CleanSpark's shares have risen by 16.36%, while the Finance sector and S&P 500 gained 2.69% and 5.12%, respectively [1] Group 2: Financial Results Expectations - CleanSpark is expected to report an EPS of -$0.03, reflecting a 400% decline compared to the same quarter last year [2] - Revenue is projected to be $195.29 million, indicating an 87.58% increase year-over-year [2] Group 3: Fiscal Year Projections - For the entire fiscal year, earnings are estimated at $0.62 per share and revenue at $777.01 million, representing increases of 338.46% and 105.03% from the previous year [3] - Recent analyst estimate revisions are crucial as they reflect confidence in CleanSpark's business performance [3] Group 4: Valuation Metrics - CleanSpark's Forward P/E ratio is currently 17.1, which is a premium compared to the industry average of 11.65 [6] - The Financial - Miscellaneous Services industry, part of the Finance sector, holds a Zacks Industry Rank of 91, placing it in the top 37% of over 250 industries [6] Group 5: Analyst Ratings - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), currently rates CleanSpark at 3 (Hold) [5] - The Zacks Consensus EPS estimate has decreased by 100% over the past month, indicating a cautious outlook [5]

Core Insights - CleanSpark achieved a significant milestone with a hashrate of 50 EH/s, leading to a 13% stock surge on June 24, 2025, and plans to scale to 60 EH/s, raising questions about its investment potential [2] - The company exhibits strong revenue growth, with a 90.1% increase in revenues over the past 12 months, reaching $537 million, significantly outpacing the S&P 500's growth [3] - CleanSpark's adjusted EBITDA margin stands at 65% for 2024, indicating solid underlying profitability despite a reported operating loss [4] - The company's financial stability is robust, with a moderate Debt-to-Equity Ratio of 23.1% and a strong cash position of $934 million [5] - CleanSpark's stock has shown weaker resilience during market downturns, with a 95.6% decline during the Inflation Shock of 2022, compared to a 25.4% decline in the S&P 500 [7] - The stock's performance is closely tied to Bitcoin's volatility, posing additional risks to its valuation [8] - Overall, CleanSpark demonstrates strong growth and adjusted profitability, with an average analyst price estimate of $20 suggesting a potential 2x upside from current levels [8]

First publicly traded miner to reach this scale with fully self-operated infrastructure LAS VEGAS, June 24, 2025 /PRNewswire/ -- CleanSpark, Inc. (Nasdaq: CLSK), America's Bitcoin Miner®, today announced it has achieved its mid-year target of 50 exahashes per second (EH/s) of operational hashrate, a measure of computing power dedicated to mining Bitcoin. "Reaching 50 EH/s is a major milestone. It reflects years of focused strategy, disciplined execution, and a relentless commitment to doing things the right ...

Group 1: Hong Kong Stocks - Lehua Entertainment (02306) surged over 24% due to strong market performance of its toy IP "WUKUKU," with multiple new products setting sales records and the theme song exceeding 1 billion views [1] - United Energy Group (00467) rose over 7% after signing a 15-year production increase contract with Uzbekistan's UNG, involving 57.8 billion cubic meters of oil and gas production, with an initial investment of $100 million to expand into Central Asia [1] - Smoore International (06969) fell over 3% as shareholder Yiwei Lithium Energy plans to reduce its stake by 3.5% (216 million shares), resulting in a decrease of its holding to 27.23%, no longer being the controlling shareholder [1] - New World Development (00200) dropped over 5% after completing a "2 for 1" rights issue, issuing 758 million shares and raising HKD 771 million, with oversubscription of 13 times [1] - Fourth Paradigm (06682) increased over 7% after launching AI solutions for the manufacturing industry, covering production optimization to supply chain intelligence upgrades [1] - Shandong High-Tech Holdings (00412) rose over 4% as Zhongtai Securities highlighted significant synergy between its new energy and digital infrastructure, with a data center PUE value of 1.15, enhancing financial integration [1] - KANAT Optical (02276) increased over 4% due to an explosion in the smart glasses market (e-commerce transactions up 8 times), with Meta collaborating with Oakley to launch AI glasses, positioning the company with leading 3C enterprises [1] Group 2: Other Notable Stocks - Sipai Health (00314) rose over 7% after partnering with Anruijiaer to develop customized insurance, planning to sell 6 pharmacies for 5.89 million to focus on core medical insurance business [2] - SF Express (09699) increased over 5% after raising its delivery service revenue cap for 2025/26 to HKD 12.8 billion / HKD 20.5 billion, with demand growth exceeding expectations [2] - Liufu Group (00590) fell over 3% as it projected a 40% decline in profits for the 2025 fiscal year, primarily due to gold hedging losses and high base effects from acquisition gains [2] - Zhenjiu Lidu (06979) rose over 4% after announcing Yao Annan as the "Cultural Heritage Ambassador" for liquor, leveraging Huawei-related topics to boost brand visibility [2] - Ideal Auto-W (02015) dropped over 4% as Meituan's Wang Xing sold 5.73 million shares for HKD 600 million, reducing his stake to 20.61% [2] - Health Road (02587) surged over 7% as its liver disease AI management platform was selected for Beijing's digital medical verification program, supporting WHO's "2030 Hepatitis Elimination" goal [2] - Gilead Sciences-B (01672) rose over 5% after its psoriasis oral drug ASC50 completed the first dosing in Phase I clinical trials in the U.S., targeting the IL-17 pathway [2] - China Silver Group (00815) increased over 10% after partnering with Zefeng Gold to acquire a 55% stake in a lead-zinc exploration company, gaining exploration rights over 50.8 square kilometers in Tibet [2] Group 3: U.S. Stocks - Verve Therapeutics (VERV.US) skyrocketed over 80% as Eli Lilly prepares to acquire the gene-editing company for up to $1.3 billion, with $1 billion as an upfront payment and $300 million contingent on specific clinical milestones [4] - Solar energy stocks plummeted, with Sunrun (RUN.US) down over 40%, Solaredge Technologies (SEDG.US) down over 41%, and First Solar (FSLR.US) down over 22%, following a Republican proposal in the U.S. Senate to terminate wind and solar tax credits by 2028, raising concerns about the industry's outlook [4] - Reddit (RDDT.US) rose over 6% after launching the AI advertising tool Reddit Insights, enhancing ad targeting through real-time user trend analysis [4] - Bitcoin-related stocks fell, with CleanSpark (CLSK.US) down over 7% and Riot Platforms (RIOT.US) down over 5%, as Bitcoin prices dropped nearly 2% to $105,580 amid escalating tensions in the Middle East and high leverage positions in the derivatives market [4] - AMD (AMD.US) continued to rise 0.56% after officially launching the Zen5 architecture Ryzen Threadripper processors, covering the workstation and desktop markets, with a market share close to 50% in China for Q1, although there are concerns about its cost-performance ratio [5] - Brain Regen Technologies (RGC.US) surged over 30% after announcing a 38-for-1 stock split, coupled with FDA clinical trial approval news, although its actual business has no revenue and a very small float, indicating significant retail speculation [6] - Jabil (JBL.US) rose over 8%, reaching a new all-time high of $202.5, with Q3 revenue increasing 15% year-on-year to $7.83 billion, raising its full-year revenue forecast to $29 billion and planning a $500 million investment to support AI data center infrastructure [6] - Niu Technologies (NIU.US) increased over 11% after launching its new NX Play electric motorcycle on Douyin, integrating a smart riding system to enhance user experience [6] - T-Mobile US (TMUS.US) fell nearly 4% as SoftBank sold 21.5 million shares at $224 each, a 3% discount, triggering market sell-off [6] - The pharmaceutical sector saw widespread declines, with Eli Lilly (LLY.US) down over 2% and Novo Nordisk (NVO.US) down over 3%, as concerns grew over the potential impact of the U.S. Senate tax bill on the industry, coupled with profit-taking ahead of some companies' earnings reports [6] - The gold sector declined, with Gold Fields (GFI.US) down over 2.1%, and spot gold fell 0.27% to $3,375.53, as easing tensions in the Middle East reduced safe-haven demand, alongside Citigroup's bearish long-term gold price forecast [7]

Core Viewpoint - CleanSpark (NASDAQ: CLSK) has experienced a significant increase in its stock price over the past few months, particularly since the lows in April, indicating positive market sentiment towards the company [1]. Company Focus - CleanSpark has primarily focused on bitcoin mining since 2020, branding itself as "America's Bitcoin Miner" [1]. Stock Performance - The appreciation in CleanSpark's stock price suggests a recovery and potential growth trajectory for the company in the bitcoin mining sector [1].

Core Insights - CleanSpark, Inc. is advancing towards a hashrate milestone of 50 EH/s with fully self-operated infrastructure, reflecting its commitment to operational control and scalability [2][3] - The company has doubled its Bitcoin treasury year-over-year to 12,502 BTC, all acquired through mining operations without issuing equity since November 2024, emphasizing disciplined capital management [2][5] - CleanSpark has expanded its contracted power capacity to 987 MW, which supports its growth strategy and operational performance [2][5] Operational Performance - In May 2025, CleanSpark maintained an average hashrate of 42.5 EH/s and achieved a month-end hashrate of 45.6 EH/s, representing a 7.5% increase sequentially [2][5] - The company produced an average of 22.39 BTC daily, with a peak single-day output of 23.50 BTC, and sold a total of 293.5 BTC at an average price of approximately $102,254 per BTC [5] - The average fleet efficiency was reported at 16.71 J/Th, indicating effective energy utilization in mining operations [7] Strategic Positioning - CleanSpark is recognized as the sixth-largest public Bitcoin holder, all mined directly through its operations, validating its infrastructure-first strategy [3] - The company aims to achieve over 60 EH/s in the future, indicating a focus on long-term growth and shareholder value [3] - CleanSpark's participation in Bitcoin 2025 highlighted its leadership in discussions on mining, energy, and digital asset management [3]

Group 1: Company Performance - NetEase-S (09999) saw a significant increase of 10.89% in stock price after reporting Q1 2025 net revenue of RMB 28.8285 billion, a year-on-year increase of 7.4%, and gross profit of RMB 18.5 billion, up 8.6% [1] - H&H International Holdings (01112) rose over 8% as the market speculated on the ergotamine concept, with its Swisse brand showing strong performance in high-growth segments [2] - China Gold International (02099) experienced a stock price increase of over 5% after reporting a 351% rise in Q1 revenue to USD 273 million [2] Group 2: Clinical and Pharmaceutical Developments - Shandong Xinhua Pharmaceutical (00719) surged over 14% as COVID-19 infections showed an upward trend, with the company preparing for Phase II clinical trials of OAB-14 [1] - Innovent Biologics (01801) rose nearly 3% after announcing the completion of the first patient dosing in the Phase III clinical study of Ma Shidu peptide for obesity [1] - Kangxi Biologics (06185) increased over 3% after receiving approval from the Indonesian drug regulatory authority for its inhaled tuberculosis vaccine clinical trial [1] Group 3: Market Trends and Reactions - The Nasdaq Golden Dragon China Index fell over 2%, with notable declines in popular Chinese stocks such as Tiger Brokers (TIGR.US) down over 8% and Beike (BEKE.US) down over 5% [3] - UnitedHealth Group (UNH.US) experienced a significant drop of over 15% following reports of a U.S. Department of Justice investigation into potential insurance fraud [3] - Bitcoin-related stocks declined, with CleanSpark (CLSK.US) down nearly 6% and Coinbase (COIN.US) down over 7%, as Bitcoin itself fell over 1.5% [3]